Abstract
There are many challenges and opportunities for nuclear cardiology in the assessment and treatment of ischemic heart disease in Asia. A short recitation of the scope of the problem in Asia, the role of nuclear cardiology, and the various impediments to the widespread, appropriate and cost-effective use of nuclear cardiology is given, together with a list of possible solutions to these hindrances applicable to Asian countries.